4//SEC Filing
Blobel Friedhelm 4
Accession 0000880771-17-000126
CIK 0000880771other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:02 PM ET
Size
8.9 KB
Accession
0000880771-17-000126
Insider Transaction Report
Form 4
Blobel Friedhelm
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-08-15−40,000→ 245,000 total→ Common Stock (40,000 underlying) - Tax Payment
Common Stock
2017-08-15$11.05/sh−20,872$230,636→ 141,337 total - Exercise/Conversion
Common Stock
2017-08-15+40,000→ 162,209 total
Footnotes (4)
- [F1]Shares disposed represent shares withheld to cover withholding tax obligations in connection with the vesting of Restricted Stock Units.
- [F2]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F3]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F4]Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeother
Related Parties
1- filerCIK 0001363213
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 8:02 PM ET
- Size
- 8.9 KB